# Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del Cardiomyopathy

> **NCT04978987** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 103 (actual)

## Conditions studied

- Phospholamban R14del Cardiomyopathy
- Heart Failure
- Cardiomyopathy, Familial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04978987
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2023-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04978987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04978987, "Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del Cardiomyopathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04978987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*